Objectives To compare the time to treatment failure, remission and first seizure of 12 AEDs
(carbamazepine, phenytoin, sodium valproate, phenobarbitone, oxcarbazepine, lamotrigine …

The purpose of this report was to update the 2006 International League Against Epilepsy
(ILAE) report and identify the level of evidence for long‐term efficacy or effectiveness for …

Status epilepticus is a life-threatening neurological emergency that affects both adults and
children. Approximately 36% of episodes of status epilepticus do not respond to the current …

Antiepileptic drugs (AEDs) have many benefits but also many side effects, including
aggression, agitation, and irritability, in some patients with epilepsy. This article offers a …

An estimated 400 million people suffer from mental or neurological disorders or from
psychosocial problems such as those related to alcohol and drug abuse. Many of them …

Purpose: To assess which antiepileptic medications (AEDs) have the best evidence for long‐
term efficacy or effectiveness as initial monotherapy for patients with newly diagnosed or …

Epilepsy is the most common serious neurological disorder and is one of the world's most
prevalent noncommunicable diseases. As the understanding of its physical and social …

Phenobarbital (PB) is the most widely used antiepileptic drug (AED) in the developing world
and remains a popular choice in many industrialized countries. Meta‐analyses of …

Objective: To examine preclinical depressive symptoms 3 years before the diagnosis of AD.
Methods: The authors compared incident AD patients and nondemented individuals in terms …

Neurocysticercosis is a disease of poverty and underdevelopment. Little is known about the
natural history of the infection in humans, but some of the mechanisms whereby the parasite …